Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

NCT00139971 is registered in ClinicalTrials.gov with West Japan Thoracic Oncology Group as lead sponsor.

NCT NCT00139971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00139971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer
Lead sponsor
West Japan Thoracic Oncology Group
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2001
Completion date
Not reported
Enrollment
600
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer